What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News A study explores the relationship between personality patterns and the different subtypes of ADHD Researchers from Vall d'Hebron Research Institute (VHIR) have established clear relationships between different personality patterns of patients with Attention Deficit Disorder and Hyperactivity Disorder (ADHD) and disorder subtypes that these patients suffer. The results of this study, published News New expectations for the treatment of metabolic diseases Researchers from Vall d'Hebron Research Institute (VHIR) lead an unprecedented study that shows that it is possible to modify the composition of the intestinal flora transplanting it, and that generated changes remain, beyond expectations, up to three months after transplantation. The ability to v News VHIR stands out in an h index ranking Researchers of Vall Hebron Institute de Recerca (VHIR) occupy a prominent position in a ranking that publishes a list of the best Spanish researchers according the h index. It consists on a method that evaluates the impact of scientific research in different areas of knowledge. According to the stud News End of Pandemic Influenza A: Reviews of Dr. Rello As coordinator of the European Registry of severe cases of A influenza, Dr. Rello, Head of Research Group on sepsis and severe respiratory infection of VHIR, summarizes the management of the first pandemic of the XXI century in the tv show 'Els Matins', of TV3. News Dr. Montalban opinion about Salvitex on the market Chief of Clinical Neuroimmunology at Vall d'Hebron Research Institute (VHIR), Dr. Xavier Montalban, talks about the green light from the health authorities to market Sativex in Spain, a drug derived from cannabis for the treatment of spasticity in multiple sclerosis patients. News Described for the first time a key protein in cell mitosis A study led by Dr. Rosanna Paciucci, member of the Biomedical Research and traslational Oncology Unit at VHIR, and published in the Journal of Biological Chemistry, describes for the first time how key is Flotilina 1 for the correct separation of chromosomes during cell mitosis. This protein, presen News Trobada entre els investigadors del Vall d'Hebron i els IDIAP Jordi Gol El passat 16 d'abril va tenir lloc la trobada entre investigadors de l'Hospital Vall d'Hebron i investigadors de l'atenció primària de salut de Catalunya, dins del marc de les VII Jornades d'Excel·lència en la Recerca d'Atenció Primària organitzades per l'Institut d'Investigació en Atenció Primària News Els fàrmacs orals aterren en el tractament de l'esclerosi múltiple Tres estudis clínics en fase III amb una àmplia mostra de pacients (cadascun inclou més de mil) han demostrat la clara eficàcia de dues molècules orals, fingolimod i cladribina, davant placebo en el tractament de l'esclerosi múltiple. En el cas de fingolimod, un dels assaigs també indica que és supe News ICS Research institutes sign an agreement with B.Braun to develope a program to investigate surgical technology Three research institutes assigned to Institut català de la salut (ICS),-Germans Trias i Pujol, Vall d’ Hebron and Bellvitge hospitals- have subscribed a research and innovation program with B.Braun Group to help investigation about surgical technology improvement. Each Institut will have a mana News Vall d' Hebron presents research activities and bets for innovation and fundraising Vall d'Hebron Research Institute presented the report of research activities 2009/10 at the conference’s room at 10th floor in the Hospital General area. The first speaker who initiated the act was the manager of the hospital, Dr. Jose Luis de Sancho. He made a positive evaluation of the work done t News Awarded a segmentary and local child glomeruloesclerosis study Catalan nephrology society (Societat catalana de nefrologia) has recently granted with best clinic work to a segmentary adn local child glomeruloesclerosis study from Vall d'Hebron Research Institute (VHIR) investigators and paediatric nephrology service from the same hospital. The study includes ne News VHIR overcomes 70 patents Diario Medico' points out in a recent article that Vall d'Hebron Research Institute (VHIR) overcomes 70 patents. It is one of the most important items in an article where last VHIR innovations are revised and where Dr. Joan X. Comella, its director, explains the state of several projects. The articl News Dr. Alijotas gives some clues about implants In a wide interview with Group Vocento 'XL Semanal', Dr Alijoats, responsible of the aging unite at Vall d'Hebron Research Institute, explains his experience with implants. News VHIR coordinates a new European Project that studies repetitive spontaneous abortions Vall d’ Hebron Research Institute (VHIR) coordinates an European register that includes information about antiphospholipid sindrome (APS) associated with bad pregnancy precedents. (spontaneous abortions, fetus deaths, complications during pregnancy…) News Vall d'Hebron Research Institute and Ilimit work together to improve communication between doctors in the CAP and specialists Vall d'Hebron Research Institute and Ilimit lead the creation of an R & D related to Information Technology (IT) applied to the health sector. News El Dr. Guarner i el Dr. Azpiroz participen a les 'XIV Jornadas de Nutrición Práctica' "Els bacteris presents en l'intestí i al còlon estan sent analitzades per descobrir les seves possibles indicacions com a alternativa bioterapéutica per prevenir i tractar alteracions gastrointestinals, segons els experts reunits a les XIV Jornades de Nutrició Pràctica .." News VHIR director invited to 'El Día del Emprendedor' Dr. Joan X. Comella, VHIR director, will participate on June 16th in the debate 'Collaborative innovation or to share to be more competitive', organised by Biocat, inside El Día del Emprendedor (The day of the undertaker).Apart from Dr. Comella, also will participate Jaume Mir, Arquebio’s general di News Dr Tabernero: Symposium about colorectal cancer Dr. Josep Maria Tabernero, Clinic Responsible of Oncology Service in Vall d’Hebron Hospital, has taken part in an international symposium called “New advances at colorectal cancer investigation”, that was held at Areces foundation in Madrid, on May 27th. News Dr. Comabella and Dr. Tabernero receive 'Merck Serono 2010' Research Grants Dr. Manel Comabella, member of Clinical Neuroimmunonology group at Vall d'Hebron Research Institute has received a research grant from Merck Serono 2010 (from Health foundation 2000) for the clinic investigation of Multiple Esclerosis.This grant is going to be used to look for alternative bioactivit News Two new genetic variants associated with Alzheimer Dr. Mercè Boada, researcher at the Vall d'Hebron Research Institute and coordinator of the ACE Foundation, has participated in a multicenter study that has identified two new genes involved in Alzheimer's disease with full tracking techniques of human genome. Pagination First page « Previous page ‹ … Page 150 Page 151 Current page 152 Page 153 Page 154 … Next page › Last page »
